17522864Gordon GJ, Mani M, Maulik G, Mukhopadhyay L, Yeap BY, Kindler HL, Salgia R, Sugarbaker DJ, Bueno RCancer chemotherapy and pharmacologyAntineoplastic Agents; Boronic Acids; Mesothelioma; Pleural Neoplasms; Proteasome Inhibitors; PyrazinesAntineoplastic Combined Chemotherapy Protocols; Apoptosis; Bortezomib; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Genes, Intracisternal A-Particle; Glutamates; Guanine; Humans; Neoplasm Proteins; Pemetrexed; Survival AnalysisPreclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):549-58.Cancer Chemother Pharmacol2007-05-24T00:00:002007Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsD001897Chemicals & Drugs28540.97053Boronic AcidsD002453Physiology1905020.841822Cell CycleD002945Chemicals & Drugs1296120.82183CisplatinD004353Procedures831030.963845Drug Evaluation, PreclinicalD005434Procedures2836790.849112Flow CytometryD008654Disorders573090.774622MesotheliomaD007426Chemicals & DrugsGenes & Molecular Sequences330.997944Genes, Intracisternal A-ParticleAuthorship 321817Authorship 321826D010997Disorders361880.842535Pleural NeoplasmsD011719Chemicals & Drugs39840.950276PyrazinesD005971Chemicals & Drugs54890.966037GlutamatesD006147Chemicals & Drugs672080.910976GuanineD006801Living Beings2262862810.130052HumansD019008Physiology1805890.751116Drug Resistance, NeoplasmMedicine-Hematology and Oncology0.07777230.07777232authors10.2524has subject areaD017209Physiology41016780.608637ApoptosisD016019Concepts & Ideas43415360.742907Survival AnalysisD018432Physiology16200.991227Drug Resistance, MultipleD045744Anatomy46824210.643233Cell Line, TumorD002470Physiology3269660.814107Cell SurvivalD00006843728760.971124PemetrexedD00006928630750.970216BortezomibD061988Chemicals & Drugs33500.97147Proteasome InhibitorsD009363Chemicals & Drugs2285320.75514Neoplasm ProteinsMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, ProfessorHedyKindler32lgBaUZHP75hHlsaUXv9Gq0+s+oHedy Kindler41.78927490000000-87.601250000000002499Kindler, HedyProfessortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessor